Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate commo...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/892f713a12fe47c58b87bf791fac1f20 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:892f713a12fe47c58b87bf791fac1f20 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:892f713a12fe47c58b87bf791fac1f202021-12-02T13:33:59ZMethyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders10.1038/s41598-020-79268-02045-2322https://doaj.org/article/892f713a12fe47c58b87bf791fac1f202020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79268-0https://doaj.org/toc/2045-2322Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate common presentations and pathophysiology across disorders. To clarify the mechanisms of these interactions, we develop a method that uses the binding properties of MeCP2 to identify its targets, and in particular, the genes recognized by MeCP2 and associated to several neurological and neuropsychiatric disorders. Analysing mechanisms and pathways modulated by these genes, we find that they are involved in three main processes: neuronal transmission, immuno-reactivity, and development. Also, while the nervous system is the most relevant in the pathophysiology of the disorders, additional systems may contribute to MeCP2 action through its target genes. We tested our results with transcriptome analysis on Mecp2-null models and cells derived from a patient with RTT, confirming that the genes identified by our procedure are directly modulated by MeCP2. Thus, MeCP2 may modulate similar mechanisms in different pathologies, suggesting that treatments for one condition may be effective for related disorders.Snow BachNiamh M. RyanPaolo GuasoniAiden P. CorvinRania A. El-NemrDanyal KhanAlbert SanfeliuDaniela TropeaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Snow Bach Niamh M. Ryan Paolo Guasoni Aiden P. Corvin Rania A. El-Nemr Danyal Khan Albert Sanfeliu Daniela Tropea Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
description |
Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate common presentations and pathophysiology across disorders. To clarify the mechanisms of these interactions, we develop a method that uses the binding properties of MeCP2 to identify its targets, and in particular, the genes recognized by MeCP2 and associated to several neurological and neuropsychiatric disorders. Analysing mechanisms and pathways modulated by these genes, we find that they are involved in three main processes: neuronal transmission, immuno-reactivity, and development. Also, while the nervous system is the most relevant in the pathophysiology of the disorders, additional systems may contribute to MeCP2 action through its target genes. We tested our results with transcriptome analysis on Mecp2-null models and cells derived from a patient with RTT, confirming that the genes identified by our procedure are directly modulated by MeCP2. Thus, MeCP2 may modulate similar mechanisms in different pathologies, suggesting that treatments for one condition may be effective for related disorders. |
format |
article |
author |
Snow Bach Niamh M. Ryan Paolo Guasoni Aiden P. Corvin Rania A. El-Nemr Danyal Khan Albert Sanfeliu Daniela Tropea |
author_facet |
Snow Bach Niamh M. Ryan Paolo Guasoni Aiden P. Corvin Rania A. El-Nemr Danyal Khan Albert Sanfeliu Daniela Tropea |
author_sort |
Snow Bach |
title |
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
title_short |
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
title_full |
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
title_fullStr |
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
title_full_unstemmed |
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders |
title_sort |
methyl-cpg-binding protein 2 mediates overlapping mechanisms across brain disorders |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/892f713a12fe47c58b87bf791fac1f20 |
work_keys_str_mv |
AT snowbach methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT niamhmryan methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT paologuasoni methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT aidenpcorvin methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT raniaaelnemr methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT danyalkhan methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT albertsanfeliu methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders AT danielatropea methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders |
_version_ |
1718392806286819328 |